Management of Myocardial Infarction with Morphine Allergy

Primary Alternative: Intravenous Nitroglycerin

The American College of Cardiology recommends administering intravenous nitroglycerin as the primary analgesic strategy for patients with myocardial infarction who are allergic to morphine, starting at 5-10 µg/min and titrating upward by 5-10 µg/min every 5-10 minutes until pain relief is achieved, combined with oral beta-blockers if hemodynamically stable 1, 2
Intravenous nitroglycerin serves as the first-line alternative analgesic when opioids fail or are contraindicated, with a Class I recommendation (Level of Evidence B) 1, 3, 4

The American Heart Association recommends oral beta-blockers to provide anti-ischemic benefit beyond simple analgesia by reducing myocardial oxygen demand, with a Class I recommendation (Level of Evidence A) 1
Administer oral metoprolol, carvedilol, or bisoprolol within the first 24 hours if hemodynamically stable, starting with low-dose oral metoprolol (25 mg) or equivalent 1

Absolute contraindication to intravenous nitroglycerin includes systolic blood pressure <90 mmHg or ≥30 mmHg below baseline, and right ventricular infarction 1
Monitor blood pressure continuously during titration of intravenous nitroglycerin 2

Administer oxygen (2-4 L/min by mask or nasal prongs) to hypoxemic patients, but avoid routine oxygen in normoxemic patients as it may increase coronary vascular resistance 2, 3, 4
Consider tranquilizers if the patient becomes excessively disturbed, but reassurance is of great importance and may be sufficient 3, 4

Effective analgesia must be promptly administered at diagnosis and should not be unreasonably delayed, as pain-associated sympathetic activation causes vasoconstriction and increases cardiac workload 2, 3, 4

If pain persists despite maximal medical therapy with IV nitroglycerin and beta-blockers, consider urgent revascularization, which indicates failed medical management and warrants immediate coronary angiography with consideration for PCI or CABG 1

Cardiac biomarkers, such as CK-MB and troponins, should be measured immediately to confirm myocardial necrosis, but do not wait for biomarker results to initiate reperfusion treatment 3, 4
Serial ECG recordings are often needed for diagnosis, and 2D echocardiography is helpful to rule out acute MI and assess wall motion abnormalities 3, 4

NSAIDs are absolutely contraindicated and must be discontinued immediately, as they are associated with increased risk of death, reinfarction, cardiac rupture, hypertension, heart failure, and renal insufficiency in MI patients 2